GC
GSK icon

Grace Capital’s GSK GSK Stock Holding History

Grace Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-7,866
Closed -$394K – 155
2019
Q2 		$394K Hold
7,866
– – 0.19% 121
2019
Q1 		$411K Hold
7,866
– – 0.16% 139
2018
Q4 		$376K Buy
7,866
+210
+3% +$10.3K 0.17% 134
2018
Q3 		$384K Hold
7,656
– – 0.15% 122
2018
Q2 		$386K Hold
7,656
– – 0.15% 134
2018
Q1 		$376K Buy
+7,656
New +$357K 0.2% 71
2017
Q1 		– Sell
-5,454
Closed -$263K – 92
2016
Q4 		$263K Hold
5,454
– – 0.12% 74
2016
Q3 		$294K Sell
5,454
-801
-13% -$43.9K 0.13% 73
2016
Q2 		$339K Sell
6,255
-58,106
-90% -$3.06M 0.14% 72
2016
Q1 		$3.26M Sell
64,361
-679
-1% -$33.8K 1.46% 34
2015
Q4 		$3.28M Sell
65,040
-35,511
-35% -$1.81M 1.55% 23
2015
Q3 		$5.48M Hold
100,551
– – 2.26% 2
2015
Q2 		$5.48M Sell
100,551
-61,493
-38% -$3.46M 2.26% 2
2015
Q1 		$9.35M Buy
162,044
+86,528
+115% +$4.96M 2.1% 4
2014
Q4 		$4.03M Buy
75,516
+20,198
+37% +$1.13M 0.97% 53
2014
Q3 		$3.18M Sell
55,318
-11,126
-17% -$682K 0.9% 60
2014
Q2 		$4.44M Buy
66,444
+44,416
+202% +$3.01M 1.22% 36
2014
Q1 		$1.47M Buy
22,028
+1,844
+9% +$125K 1.54% 24
2013
Q4 		$1.35M Buy
20,184
+728
+4% +$47.2K 1.56% 26
2013
Q3 		$1.22M Buy
19,456
+688
+4% +$44.3K 1.54% 31
2013
Q2 		$1.17M Buy
+18,768
New +$1.19M 1.59% 28

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Grace Capital's GSK Position: Q3 2019 in Review

Grace Capital sold out of GSK (GSK) in Q3 2019, closing a stake of 7,866 shares — an estimated $394K sold.

Grace Capital first reported a position in GSK in Q2 2013 and held it in 21 quarters. The position peaked at $9.35M in Q1 2015. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

  • Grace Capital reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
  • Grace Capital sold 7,866 GSK shares in Q3 2019, an estimated $394K.
  • Grace Capital first reported a position in GSK in Q2 2013 and held it in 21 quarters.
  • Grace Capital's GSK position peaked at $9.35M in Q1 2015.
  • 805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Grace Capital's 13F filing for Q3 2019, filed 15 Nov 2019.